Kilitch Drugs (India) is setting up its second green field project in Ethiopia to manufacture liquid injectables and at a capital investment of $5 million. In this regard, the company has accepted the request of Ethiopian government for one hector land near Addis Ababa.
At the same time, the company’s first manufacturing plant has also reached a decisive stage of the completion process. The company has begun installing machinery at the first Addis Ababa manufacturing unit and is all scheduled to commence the validation process this month (December). Further, this also ensures that the quality assurance techniques used to build the quality into the product at every step is up to the desired standards.
Kilitch Drugs (India) is an India-based company engaged in pharmaceutical business. The Company’s services range from manufacturing to marketing a host of formulations in all dosage forms, such as solid, liquid and parenteral forms.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: